Skip to content
Screener

LifeMD, Inc. LFMD Q2 2025 earnings

Reported August 4, 2025 · After market close

Revenue$62.2MMiss by $4.1M
EPS-$0.05Miss by $0.23
Revenue estimate$66.3M
EPS estimate$0.18

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$48.9M
EPS estimate-$0.14

Financials

Q2 2025

Income statement

See full
Revenue$62.7M+23.7%
Gross profit$55.2M+21.0%
Operating income-$451.6K+92.8%
Net income-$1.6M+76.4%
EPS (diluted)-$0.06+68.4%

Balance sheet

See full
Cash & equivalents$36.2M+23.6%
Total debt$34.4M+225%
Total equity-$1.8M+57.6%
Total assets$73.6M+15.3%

Cash flow

See full
Operating cash flow$8.6M+90.3%
CapEx$800.4K+24.7%
Free cash flow$7.8M+101%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$638.54M+137%
Enterprise value$636.75M+154%
P/S3.7×+2.2×

Profitability

See full
Gross margin84.9%-4.0pp
Operating margin-6.7%-1.8pp
Net margin-6.6%-2.2pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Current ratio0.8×-0.1×

Segments

By segment

See full
Telehealth$48.6M+29.7%
Telehealth Subscription Revenue$29.2M—

FAQ

When did LifeMD, Inc. report Q2 2025 earnings?
LifeMD, Inc. (LFMD) reported Q2 2025 earnings on August 4, 2025 after market close.
What were LifeMD, Inc.'s Q2 2025 revenue and EPS?
LifeMD, Inc. reported revenue of $62.2M and eps of $-0.05 for Q2 2025.
Did LifeMD, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $66.3M by $4.1M. EPS missed the consensus estimate of $0.18 by $0.23.
How did LifeMD, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.8% from $50.7M a year earlier and eps grew 75.4% from $-0.19.
Where can I find LifeMD, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001641172-25-022258) and the 10-Q periodic report (0001641172-25-022272) directly on SEC EDGAR. The filing index links above go to sec.gov.